Tc17 Cells in Immunity and Systemic Autoimmunity

REFERENCES

• Romagnani S, Del Prete G, Manetti R, et al. Role of TH1/TH2 cytokines in HIV infection. Immunol Rev 1994;140:73–92.
   PubMed Web of Science ®Google Scholar
• Noack M, Miossec P. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun Rev 2014;13(6):668–677.
   PubMed Web of Science ®Google Scholar
• Fenoglio D, Bernuzzi F, Battaglia F, et al. Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases. Autoimmun Rev 2012;12(2):300–304.
   PubMed Web of Science ®Google Scholar
• Weaver CT, Harrington LE, Mangan PR, et al. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006;24(6):677–688.
   PubMed Web of Science ®Google Scholar
• McAleer JP, Kolls JK. Mechanisms controlling Th17 cytokine expression and host defense. J Leukoc Biol 2011;90(2):263–270.
   PubMed Web of Science ®Google Scholar
• Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR. Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 2007;6(3):169–175.
   PubMed Web of Science ®Google Scholar
• Yen HR, Harris TJ, Wada S, et al. Tc17 CD8 T cells: functional plasticity and subset diversity. J Immunol 2009;183(11):7161–7168.
   PubMed Web of Science ®Google Scholar
• Hamada H, Garcia-Hernandez Mde L, Reome JB, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol 2009;182(6):3469–3481.
   PubMed Web of Science ®Google Scholar
• Kondo T, Takata H, Matsuki F, et al. Cutting edge: phenotypic characterization and differentiation of human CD8+ T cells producing IL-17. J Immunol 2009;182(4):1794–1798.
   PubMed Web of Science ®Google Scholar
• Huber M, Heink S, Pagenstecher A, et al. IL-17A secretion by CD8+T cells supports Th17-mediated autoimmune encephalomyelitis. J Clin Invest 2013;123(1):247–260.
   PubMed Web of Science ®Google Scholar
• Huber M, Heink S, Grothe H, et al. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity. Eur J Immunol 2009;39(7):1716–1725.
   PubMed Web of Science ®Google Scholar
• Ciric B, El-behi M, Cabrera R, et al. IL-23 drives pathogenic IL-17-producing CD8+ T cells. J Immunol 2009;182(9):5296–5305.
   PubMed Web of Science ®Google Scholar
• Saxena A, Desbois S, Carrié N, et al. Tc17 CD8+ T cells potentiate Th1-mediated autoimmune diabetes in a mouse model. J Immunol 2012;189(6):3140–3149.
   PubMed Web of Science ®Google Scholar
• Kryczek I, Bruce AT, Gudjonsson JE, et al. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol 2008;181(7):4733–4741.
   PubMed Web of Science ®Google Scholar
• Happel KI, M Zheng, E Young, et al. Cutting edge: role of toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol 2003;170(9):4432–4436.
   PubMed Web of Science ®Google Scholar
• He D, Wu L, Kim HK, et al. CD8 +IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J Immunol 2006;177(10):6852–6858.
   PubMed Web of Science ®Google Scholar
• Curtis MM, Way SS, Wilson CB. IL-23 promotes the production of IL-17 by antigen-specific CD8 T cells in the absence of IL-12 and type-I interferons. J Immunol 2009;183(1):381–387.
   PubMed Web of Science ®Google Scholar
• Kuang DM, Peng C, Zhao Q, et al. Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients. J Immunol 2010;185(3):1544–1549.
   PubMed Web of Science ®Google Scholar
• Sarin R, Wu X, Abraham C. Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. Proc Natl Acad Sci USA 2011;108(23):9560–9565.
   PubMed Web of Science ®Google Scholar
• Liu SJ, Tsai JP, Shen CR, et al. Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6. J Leukoc Biol 2007;82(2):354–360.
   PubMed Web of Science ®Google Scholar
• Smyth MJ, Ortaldo JR, Bere W, et al. IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. J Immunol 1990;145(4):1159–1166.
   PubMed Web of Science ®Google Scholar
• Dwivedi VP, Tousif S, Bhattacharya D, et al. Transforming growth factor-β protein inversely regulates in vivo differentiation of interleukin-17 (IL-17)-producing CD4+ and CD8+ T cells. J Biol Chem 2012;287(5):2943–2947.
   PubMed Web of Science ®Google Scholar
• Satoh T, Tajima M, Wakita D, et al. The development of IL-17/IFN-γ-double producing CTLs from Tc17 cells is driven by epigenetic suppression of Socs3 gene promoter. Eur J Immunol 2012;42(9):2329–2342.
   PubMed Web of Science ®Google Scholar
• Morishima N, Mizoguchi I, Okumura M, et al. A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes. J Biomed Biotechnol 2010;2010:605483.
   PubMed Web of Science ®Google Scholar
• Stumhofer JS, Laurence A, Wilson EH, et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 2006;7(9):937–945.
   PubMed Web of Science ®Google Scholar
• Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol 2012;12(3):180–190.
   PubMed Web of Science ®Google Scholar
• Tsai JP, Lee MH, Hsu SC, et al. CD4+ T cells disarm or delete cytotoxic T lymphocytes under IL-17-polarizing conditions. J Immunol 2012;189(4):1671–1679.
   PubMed Web of Science ®Google Scholar
• Pick J, Arra A, Lingel H, et al. CTLA-4 (CD152) enhances the Tc17 differentiation program. Eur J Immunol 2014 Apr 10.
   PubMed Web of Science ®Google Scholar
• Rubino SJ, Geddes K, Magalhaes JG, et al. Constitutive induction of intestinal Tc17 cells in the absence of hematopoietic cell-specific MHC class II expression. Eur J Immunol 2013;43(11):2896–2906.
   PubMed Web of Science ®Google Scholar
• Intlekofer AM, Banerjee A, Takemoto N, et al. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 2008;321(5887):408–411.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Ju S, Chen E, et al. T-bet and eomesodermin are required for T cell-mediated antitumor immune responses. J Immunol 2010;185(6):3174–3183.
   PubMed Web of Science ®Google Scholar
• Burrell BE, Csencsits K, Lu G, et al. CD8+Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice. J Immunol 2008;181(6):3906–3914.
   PubMed Web of Science ®Google Scholar
• Skepner J, Ramesh R, Trocha M, et al. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo. J Immunol 2014;192(6): 2564–2575.
   PubMed Web of Science ®Google Scholar
• Ysebrant de Lendonck L, Tonon S, Nguyen M, et al. Interferon regulatory factor 3 controls interleukin-17 expression in CD8 T lymphocytes. Proc Natl Acad Sci U S A 2013;110(34):E3189–E3197.
   PubMed Web of Science ®Google Scholar
• Thomas RM, Sai H, Wells AD. Conserved intergenic elements and DNA methylation cooperate to regulate transcription at the il17 locus. J Biol Chem2012;287(30):25049–25059.
   PubMed Web of Science ®Google Scholar
• Yu CR, Dambuza IM, Lee YJ, et al. STAT3 regulates proliferation and survival of CD8+ T cells: enhances effector responses to HSV-1 infection, and inhibits IL-10+ regulatory CD8+ T cells in autoimmune uveitis. Mediators Inflamm 2013;2013:359674.
   PubMed Web of Science ®Google Scholar
• Yeh N, Glosson NL, Wang N, et al. Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype. J Immunol 2010;185(4):2089–2098.
   PubMed Web of Science ®Google Scholar
• Tajima M, Wakita D, Satoh T, et al. IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12. Int Immunol 2011;23(12):751–759.
   PubMed Web of Science ®Google Scholar
• Peelen E, Thewissen M, Knippenberg S, et al. Fraction of IL-10 +and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators. J Neuroimmunol 2013;258(1–2):77–84.
   PubMed Web of Science ®Google Scholar
• Henriques A, Gomes V, Duarte C, et al. Distribution and functional plasticity of peripheral blood Th(c)17 and Th(c)1 in rheumatoid arthritis. Rheumatol Int 2013;33(8):2093–2099.
   PubMed Web of Science ®Google Scholar
• Henriques A, Inês L, Couto M, et al. Frequency and functional activity of Th17, Tc17 and other T-cell subsets in Systemic Lupus Erythematosus. Cell Immunol 2010;264(1):97–103.
   PubMed Web of Science ®Google Scholar
• Tajima M, Wakita D, Noguchi D, et al. IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8 +T cells. J Exp Med 2008;205(5):1019–1027.
   PubMed Web of Science ®Google Scholar
• Res PC, Piskin G, de Boer OJ, et al. Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS One 2010;5(11):e14108.
   PubMed Web of Science ®Google Scholar
• Jänner N, Hahnke K, Mollenkopf HJ, et al. Restricted expression of C-type lectin-like natural killer receptors by CD8 T cells in the murine small intestine. Immunology 2008;125(1):38–47.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Dejbakhsh-Jones S, Strober S. Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities. J Immunol 2006;176(1):211–216.
   PubMed Web of Science ®Google Scholar
• Billerbeck E, Kang YH, Walker L, et al. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci U S A 2010;107(7):3006–3011.
   PubMed Web of Science ®Google Scholar
• Annibali V, Ristori G, Angelini DF, et al. CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis. Brain 2011;134(Pt2):542–554.
   PubMed Web of Science ®Google Scholar
• Lanier LL, Chang C, Phillips JH. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 1994;153(6): 2417–2428.
   PubMed Web of Science ®Google Scholar
• Maggi L, Santarlasci V, Capone M, et al. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur J Immunol 2010;40(8):2174–2181.
   PubMed Web of Science ®Google Scholar
• Northfield JW, Kasprowicz V, Lucas M, et al. CD161 expression on hepatitis C virus-specific CD8 +T cells suggests a distinct pathway of T cell differentation. Hepatology 2008;47(2):396–406.
   PubMed Web of Science ®Google Scholar
• Guillot-Delost M, Le Gouvello S, Mesel-Lemoine M, et al. Human CD90 identifies Th17/Tc17 T cell subsets that are depleted in HIV-infected patients. J Immunol 2012;188(3):981–991.
   PubMed Web of Science ®Google Scholar
• Dagur PK, Biancotto A, Stansky E, Sen HN, et al. Secretion of interleukin-17 by CD8+T cells expressing CD146 (MCAM). Clin Immunol 2014;152(1–2):36–47.
   PubMed Web of Science ®Google Scholar
• Haeryfar SM, Conrad DM, Musgrave B, et al. Antibody blockade of Thy-1 (CD90) impairs mouse cytotoxic T lymphocyte induction by anti-CD3 monoclonal antibody. Immunol Cell Biol 2005;83(4):352–363.
   PubMed Web of Science ®Google Scholar
• Tzartos JS, Friese MA, Craner MJ, et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 2008;172(1):146–155.
   PubMed Web of Science ®Google Scholar
• Hu Y, Ma DX, Shan NN, et al. Increased number of Tc17 and correlation with Th17 cells in patients with immune thrombocytopenia. PLoS One 2011;6(10):e26522.
   PubMed Web of Science ®Google Scholar
• Xu X, Zheng S, Yang F, et al. Increased Th22 cells are independently associated with Th17 cells in type 1 diabetes. Endocrine 2014;46(1):90–98.
   PubMed Web of Science ®Google Scholar
• Eysteinsdóttir JH, Sigurgeirsson B, Ólafsson JH, et al. The role of Th17/Tc17 peripheral blood T cells in psoriasis and their positive therapeutic response. Scand J Immunol 2013;78(6):529–537.
   PubMed Web of Science ®Google Scholar
• Menon B, Gullick NJ, Walter GJ, et al. IL-17+CD8+ T-cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression. Arthritis Rheumatol 2014;66(5):1272–1281.
   PubMed Web of Science ®Google Scholar
• Yu Y, Cho HI, Wang D, et al. Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanisms. J Immunol 2013;190(4):1873–1881.
   PubMed Web of Science ®Google Scholar
• Nanjappa SG, Heninger E, Wüthrich M, et al. Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells. PLoS Pathog 2012;8(7):e1002771.
   PubMed Web of Science ®Google Scholar
• Cheuk S, Wikén M, Blomqvist L, et al. Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis. J Immunol 2014;192(7):3111–3120.
   PubMed Web of Science ®Google Scholar
• Yu Y, Cho HI, Wang D, et al. Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanisms. J Immunol 2013;190(4):1873–1881.
   PubMed Web of Science ®Google Scholar
• Garcia-Hernandez Mde L, Hamada H, Reome JB, et al. Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice. J Immunol 2010;184(8):4215–4227.
   PubMed Web of Science ®Google Scholar
• Kuang DM, Peng C, Zhao Q, et al. Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinomapatients. J Immunol 2010;185(3):1544–1549.
   PubMed Web of Science ®Google Scholar
• Zhuang Y, Peng LS, Zhao YL, et al. CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer. Gastroenterology 2012;143(4):951–962.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hou F, Liu X, et al. Tc17 cells in patients with uterine cervical cancer. PLoS One 2014;9(2):e86812.
   PubMed Web of Science ®Google Scholar
• Zhao XY, Xu LL, Lu SY, et al. IL-17-producing T cells contribute to acute graft-versus-host disease in patients undergoing unmanipulated blood and marrow transplantation. Eur J Immunol 2011;41(2):514–526.
   PubMed Web of Science ®Google Scholar
• Lai HY, Chou TY, Tzeng CH, et al. Cytokine profiles in various graft-versus-host disease target organs following hematopoietic stem celltransplantation. Cell Transplant 2012;21(9):2033–2045.
   PubMed Web of Science ®Google Scholar